Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid
Enhanced P53 and BAX gene expression and apoptosis in A549 cells by cis-Pt(II) complex of 3-aminoflavone in comparison with cis-DDP
A study of cytotoxic synergy of UCN-01 and flavopiridol in syngeneic pair of cell lines*
A phase I pharmacokinetic study of the P-glycoprotein inhibitor, ONT-093, in combination with paclitaxel in patients with advanced cancer
Human metabolism of [14C]indisulam following i.v. infusion in cancer patients
Phase I/II study of amrubicin, a novel 9-aminoanthracycline, in patients with advanced non-small-cell lung cancer
DE-310, a macromolecular prodrug of the topoisomerase-I-inhibitor exatecan (DX-8951), in patients with operable solid tumors
Gemcitabine and mitoxantrone in metastatic breast cancer : A phase-I-study
Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme
BBR 3438, a novel 9-aza-anthrapyrazole, in patients with advanced gastric cancer : A phase II study group trial of the central European Society of Anticancer-Drug Research (CESAR)
Second-line treatment with oxaliplatin, leucovorin and 5-fluorouracil in gemcitabine-pretreated advanced pancreatic cancer : A phase II study
Erratum
Erratum